Market Overview

Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduciary Duty by the Board of Directors of LCA-Vision, Inc. in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV

Share:

STEVENSON, Md., Feb. 21, 2014 (GLOBE NEWSWIRE) -- The securities litigation firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in Delaware state court on behalf of all common stockholders of LCA-Vision, Inc. ("LCA" or the "Company") (Nasdaq: LCAV).

The claims concern whether the LCA Board of Directors breached their fiduciary duties to stockholders by failing to maximize shareholder value before agreeing to enter into this transaction and whether PhotoMedex is underpaying for LCA shares. Under the terms of the transaction, LCA shareholders will receive $5.37 for each share of LCA common stock they own. The transaction has a total approximate value of $106.4 million.

According to Yahoo! Finance, at least one analyst following LCA has set a target price of $6.50 per share.

If you currently own common stock of LCA and would like to learn more about the lawsuit, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at hoffman@browerpiven.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.

CONTACT: Brower Piven, A Professional Corporation Stevenson, Maryland Charles J. Piven, 410-415-6616 hoffman@browerpiven.com
View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com